إعلان
إعلان

LFST

LFST logo

LifeStance Health Group, Inc. Common Stock

7.30
USD
برعاية
+0.02
+0.32%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

7.30

0.00
+0.03%

تقارير أرباح LFST

النسبة الإيجابية المفاجئة

LFST تفوق 10 من 18 آخر التقديرات.

56%

التقرير التالي

بيانات التقرير القادم
٢٦ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$385.60M
/
$0.00
التغير الضمني من Q3 25 (Revenue/ EPS)
+5.99%
/
--
التغير الضمني من Q4 24 (Revenue/ EPS)
+18.47%
/
-100.00%

LifeStance Health Group, Inc. Common Stock earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, LFST reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of -0.01 USD, resulting in a 100.00% surprise. Revenue reached 363.81 مليون, compared to an expected 362.72 مليون, with a 0.30% difference. The market reacted with a +29.94% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 المحللين forecast an EPS of 0.00 USD, with revenue projected to reach 385.60 مليون USD, implying an زيادة of 0.00% EPS, and زيادة of 5.99% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, LifeStance Health Group, Inc. Common Stock reported EPS of $0.00, beating estimates by 100%, and revenue of $363.81M, 0.3% above expectations.
The stock price moved up 29.94%, changed from $4.81 before the earnings release to $6.25 the day after.
The next earning report is scheduled for ٢٦ فبراير ٢٠٢٦.
Based on 11 المحللين, LifeStance Health Group, Inc. Common Stock is expected to report EPS of -- and revenue of $385.60M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان